NHS National Framework Agreement for the supply of Eculizumab - 1 Feb 2024

NHS National Framework Agreement for the supply of Eculizumab - 1 Feb 2024

Offer reference number: CM/PHR/22/5693

Period of framework: 1 February 2024 to 30 April 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

Additional information:

To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome.

Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at:

Phone: 0800 9956035

E-mail: …@atamis.co.uk

Tender Documents

• Opportunity notice on Contracts Finder → — Tender notice
• Document No. 02 - Terms of offer →
• Document No. 07a - Quality control technical sheet →
• Document No. 06 - Form of offer - CM-PHR-22-5693 →
• Document No. 04b - Assessment Criteria, Stability Protocol and Additional Specification Requirements →
• Document No. 05 - Selectt offer schedule instructions - CM-PHR-22-5693 →
• Document No. 05a - Selectt Offer Schedule - CM_PHR_22_5693_00 →
• Document No. 09 - Tender design and instructions on completing the offer schedule - CM-PHR-22-5693 →
• Document No. 10 - Pharmacy Purchasing Points List - CM-PHR-22-5693 →
• Document No. 00 - Read Me First Document →
• Document No. 01 - Invitation to offer covering letter - CM-PHR-22-5693 →
• Document No. 03 - Framework Agreement and Terms and Conditions Branded →
• Document No. 04a - Quality Assurance Process →
• Document No. 05c - Volume discounts or Additional Products Offer Schedule - CM-PHR-22-5693 →
• Document No. 08 - Confidential information schedule - CM-PHR-22-5693 →